These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 38501355)

  • 21. Activity of temocillin against ESBL-, AmpC-, and/or KPC-producing Enterobacterales isolated in Poland.
    Kuch A; Zieniuk B; Żabicka D; Van de Velde S; Literacka E; Skoczyńska A; Hryniewicz W
    Eur J Clin Microbiol Infect Dis; 2020 Jun; 39(6):1185-1191. PubMed ID: 32096107
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cefoxitin as an alternative to carbapenems in a murine model of urinary tract infection due to Escherichia coli harboring CTX-M-15-type extended-spectrum β-lactamase.
    Lepeule R; Ruppé E; Le P; Massias L; Chau F; Nucci A; Lefort A; Fantin B
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1376-81. PubMed ID: 22214774
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The antimicrobial activity of mecillinam, nitrofurantoin, temocillin and fosfomycin and comparative analysis of resistance patterns in a nationwide collection of ESBL-producing Escherichia coli in Norway 2010-2011.
    Zykov IN; Sundsfjord A; Småbrekke L; Samuelsen Ø
    Infect Dis (Lond); 2016 Feb; 48(2):99-107. PubMed ID: 26414659
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of amoxycillin-clavulanate in an experimental model of murine pneumonia caused by AmpC-non-hyperproducing clinical isolates of Escherichia coli resistant to cefoxitin.
    Docobo-Pérez F; Fernández-Cuenca F; Pachón-Ibáñez ME; Pascual A; Pichardo C; Martínez-Martínez L; Pachón J
    Clin Microbiol Infect; 2008 Jun; 14(6):582-7. PubMed ID: 18294246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In Vitro Efficacy of Six Alternative Antibiotics against Multidrug Resistant Escherichia Coli and Klebsiella Pneumoniae from Urinary Tract Infections.
    Chen YT; Ahmad Murad K; Ng LS; Seah JT; Park JJ; Tan TY
    Ann Acad Med Singap; 2016 Jun; 45(6):245-50. PubMed ID: 27412057
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activity of temocillin and 15 other agents, including fosfomycin and colistin, against Enterobacteriaceae in Hong Kong.
    Ip M; Lai CK; Fung KSC; Wong KT; Zhu C; Van de Velde S; Tsang DN; Hawkey P
    Eur J Clin Microbiol Infect Dis; 2017 Dec; 36(12):2491-2494. PubMed ID: 28840351
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of low-level fluoroquinolone resistance genes qnrA1, qnrB19 and qnrS1 on ciprofloxacin treatment of isogenic Escherichia coli strains in a murine urinary tract infection model.
    Jakobsen L; Cattoir V; Jensen KS; Hammerum AM; Nordmann P; Frimodt-Møller N
    J Antimicrob Chemother; 2012 Oct; 67(10):2438-44. PubMed ID: 22685162
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Temocillin. In vitro antibacterial activity.
    Slocombe B; Cooper CE; Griffin KE; White AR
    Drugs; 1985; 29 Suppl 5():49-56. PubMed ID: 3849425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of Paradoxical Efficacy of Carbapenems against Carbapenemase-Producing Escherichia coli in a Murine Model of Lethal Peritonitis.
    Roujansky A; de Lastours V; Guérin F; Chau F; Cheminet G; Massias L; Cattoir V; Fantin B
    Antimicrob Agents Chemother; 2020 Jul; 64(8):. PubMed ID: 32423956
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fitness cost constrains the spectrum of marR mutations in ciprofloxacin-resistant Escherichia coli.
    Praski Alzrigat L; Huseby DL; Brandis G; Hughes D
    J Antimicrob Chemother; 2017 Nov; 72(11):3016-3024. PubMed ID: 28962020
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cefotaxime and Amoxicillin-Clavulanate Synergism against Extended-Spectrum-β-Lactamase-Producing Escherichia coli in a Murine Model of Urinary Tract Infection.
    Rossi B; Soubirou JF; Chau F; Massias L; Dion S; Lepeule R; Fantin B; Lefort A
    Antimicrob Agents Chemother; 2016 Jan; 60(1):424-30. PubMed ID: 26525800
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Temocillin susceptibility among Enterobacterales strains recovered from blood culture in France.
    Farfour E; Si Larbi AG; Cattoir V; Corvec S; Guillard T; Grillon A; Isnard C; Mérens A; Degand N; Billard-Pomares T; Fournier D; Bille E; Le Brun C; Plouzeau C; Flevin E; Yin N; Woerther PL; Lourtet J; Lesprit P; Le Monnier A;
    Diagn Microbiol Infect Dis; 2021 Jul; 100(3):115368. PubMed ID: 33813355
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanisms of intrinsic resistance and acquired susceptibility of Pseudomonas aeruginosa isolated from cystic fibrosis patients to temocillin, a revived antibiotic.
    Chalhoub H; Pletzer D; Weingart H; Braun Y; Tunney MM; Elborn JS; Rodriguez-Villalobos H; Plésiat P; Kahl BC; Denis O; Winterhalter M; Tulkens PM; Van Bambeke F
    Sci Rep; 2017 Jan; 7():40208. PubMed ID: 28091521
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of temocillin efficacy against KPC-2-producing Klebsiella pneumoniae isolates in a hollow-fibre infection model.
    Rodríguez-Ochoa JL; Pérez-Palacios P; Merino-Bohórquez V; Ortiz-Padilla M; Velázquez-Escudero A; Rodríguez-Baño J; Rodríguez-Martínez JM; Pascual Á; Docobo-Pérez F
    J Antimicrob Chemother; 2024 Apr; 79(4):784-789. PubMed ID: 38334407
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Broad-spectrum beta-lactams for treating experimental peritonitis in mice due to Escherichia coli producing plasmid-encoded cephalosporinases.
    Vimont S; Aubert D; Mazoit JX; Poirel L; Nordmann P
    J Antimicrob Chemother; 2007 Nov; 60(5):1045-50. PubMed ID: 17804425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic experience with temocillin in peritonitis.
    Pfeiffer M; Fock RR
    Drugs; 1985; 29 Suppl 5():194-6. PubMed ID: 3896740
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sulopenem: An Intravenous and Oral Penem for the Treatment of Urinary Tract Infections Due to Multidrug-Resistant Bacteria.
    Zhanel GG; Pozdirca M; Golden AR; Lawrence CK; Zelenitsky S; Berry L; Schweizer F; Bay D; Adam H; Zhanel MA; Lagacé-Wiens P; Walkty A; Irfan N; Naber K; Lynch JP; Karlowsky JA
    Drugs; 2022 Apr; 82(5):533-557. PubMed ID: 35294769
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The prevalence and mechanism of triclosan resistance in Escherichia coli isolated from urine samples in Wenzhou, China.
    Zeng W; Xu W; Xu Y; Liao W; Zhao Y; Zheng X; Xu C; Zhou T; Cao J
    Antimicrob Resist Infect Control; 2020 Oct; 9(1):161. PubMed ID: 33008474
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tigecycline Nonsusceptibility Occurs Exclusively in Fluoroquinolone-Resistant Escherichia coli Clinical Isolates, Including the Major Multidrug-Resistant Lineages O25b:H4-ST131-H30R and O1-ST648.
    Sato T; Suzuki Y; Shiraishi T; Honda H; Shinagawa M; Yamamoto S; Ogasawara N; Takahashi H; Takahashi S; Tamura Y; Yokota SI
    Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27855067
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of Cefotaxime-Resistant Escherichia coli Isolates from Healthy Cattle and Sheep in Northern Spain: Phenotypic and Genome-Based Characterization of Antimicrobial Susceptibility.
    Tello M; Ocejo M; Oporto B; Hurtado A
    Appl Environ Microbiol; 2020 Jul; 86(15):. PubMed ID: 32471914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.